Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Deborah Yoong"'
Publikováno v:
Canadian Medical Education Journal (2023)
Implication Statement We developed a pharmacist-led one-month teaching rotation for medical residents to learn HIV pharmacotherapy. This interprofessional education (IPE) was deemed extremely valuable by postgraduate-year-3 residents who intended t
Externí odkaz:
https://doaj.org/article/3c415cbc5322438ea5e369f05b09790f
Autor:
Steven A Morrison, Deborah Yoong, Trevor A Hart, Paul MacPherson, Isaac Bogoch, Vishalini Sivarajah, Kevin Gough, Mark Naccarato, Darrell H S Tan
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197998 (2018)
INTRODUCTION:The standard clinical approach to non-occupational HIV post-exposure prophylaxis (nPEP) focuses on biomedical aspects of the intervention, but may overlook co-occurring or 'syndemic' psychosocial problems that reinforce future vulnerabil
Externí odkaz:
https://doaj.org/article/0bad361657fc41e4afb99c3995d1f9a6
Autor:
Shivali Suri, Rob J. Fredericksen, Deborah Yoong, Duncan Short, Heidi M. Crane, Alexandra Musten, Darrell H. S. Tan, Kevin Gough, William B. Lober, Mark Naccarato
Publikováno v:
International journal of STDAIDS. 33(3)
Background: An optimal adherence to antiretroviral therapy (ART) is fundamental for suppression of HIV viral load and favourable treatment outcomes. Patient-reported outcomes (PROs) are effective tools for improving patient–provider communication a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3315543336c0e17c11c91af7c65149cb
https://pubmed.ncbi.nlm.nih.gov/34293990
https://pubmed.ncbi.nlm.nih.gov/34293990
Publikováno v:
Dermatology Reports, Vol 5, Iss 1, Pp e1-e1 (2013)
Current standard of treatment for chronic hepatitis C virus infection requires the use of pegylated interferon plus ribavirin. Treatment with these two agents has been associated with numerous side effects, which frequently include dermatologic erupt
Externí odkaz:
https://doaj.org/article/2a746d0c5b8b49b5841f1840f93c0ce5
Autor:
Holly Gauvin, Deborah Yoong, Ron Rosenes, Tony Antoniou, Ryan Peck, Maureen Owino, Claire Kendall, Seungwon Nam, Llewellyn Goddard, Adrian Betts, Beth Rachlis, Ontario Hiv Drug Coverage Study Team, Sean B. Rourke, Andrea Sharp, Terry Santoni
Publikováno v:
AIDS care. 33(6)
Antiretroviral medications are expensive, and people living with HIV often experience challenges accessing and paying for medication due to various obstacles. We used concept mapping to explore the challenges people living with HIV in Ontario, Canada
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd73f5eb0f9fe2e94507bd1e6cebec4
https://pubmed.ncbi.nlm.nih.gov/32490685
https://pubmed.ncbi.nlm.nih.gov/32490685
Publikováno v:
CMAJ Open. 6:E551-E560
Background Antiretrovirals are expensive and people living with HIV may experience a range of financial burdens when accessing these medications. Our aim was to describe the policy of all Canadian public drug insurance programs for antiretroviral dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33b201d0330eb268b33f18105df65eb3
https://doi.org/10.9778/cmajo.20180058
https://doi.org/10.9778/cmajo.20180058
Publikováno v:
AIDS. 33:1261-1263
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48d07bd20bb4a8dfe5e12dba59f9b15c
https://doi.org/10.1097/qad.0000000000002191
https://doi.org/10.1097/qad.0000000000002191
Publikováno v:
Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC. 152(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::380350c9a2c8378ebb05f72d4e1a98ac
https://pubmed.ncbi.nlm.nih.gov/30886661
https://pubmed.ncbi.nlm.nih.gov/30886661
Publikováno v:
International Journal of STD & AIDS. 27:608-616
Pre-exposure prophylaxis (PrEP) has been shown to reduce the risk of HIV transmission but has the potential to cause harm if not used properly. Pharmacists are well-positioned to foster PrEP’s efficacy but little is known whether they would endorse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71449eaa2ae197e6f758bea18e77693b
https://doi.org/10.1177/0956462415589896
https://doi.org/10.1177/0956462415589896
Autor:
Marianne Harris, Stephen D. Shafran, Gilles Lambert, Tim Rogers, Réjean Thomas, Christine A. Hughes, Darrell H. S. Tan, Shannon O’Donnell, Joseph Cox, Lisa Barrett, Julie Kille, Joss Reimer, Pierre Giguère, Jody Jollimore, Ameeta E. Singh, Jean-Guy Baril, Cécile Tremblay, Isaac I. Bogoch, Gila Metz, Bertrand Lebouché, Deborah Yoong, Paul MacPherson, Patrick O'Byrne, Mark Hull
KEY POINTS New HIV infections occur every year in Canada,[1][1] highlighting the need for integrated prevention programs. Pre-exposure prophylaxis (PrEP) and nonoccupational postexposure prophylaxis (nPEP) are two important strategies for preventing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89317df6d91169c4933d6303841871ac
https://europepmc.org/articles/PMC5703677/
https://europepmc.org/articles/PMC5703677/
